Acarbose: Research, Dosing, and Where to Buy in 2026
A research-first profile for Acarbose (Acarbose), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Acarbose is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 4 attributed expert mentions for Acarbose, each linked to its source.
- Also indexed as Acarbose.
- 0 aggregated dosing-protocol mentions from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is Acarbose?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
Experts on background and overview · 1 cited mention
"Acarbose is a I think it prevents the metabolism of starches or long slow digestible carbohydrates. And then prevents the production of glucose, basically."
Acarbose Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
No transcript-derived dosing mentions in current source set.
Where to Buy Acarbose in 2026
No tracked vendor recommendations for Acarbose yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
What Experts Say
1 expert across our source library discuss Acarbose. Each entry is that expert’s most context-rich mention: click to watch it at the exact timestamp in the original video. Quotes are also emitted as Schema.org Quotation JSON-LD for AI assistants.
-
“Acarbose is a I think it prevents the metabolism of starches or long slow digestible carbohydrates. And then prevents the production of glucose, basically.”
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Acarbose. Each line links to the original source.
- "Weight mean difference (WMD) was - 0.21 (95% CI - 0.33, - 0.09) mmol/l between acarbose (P = 0.0006) and placebo patients." · Yu A et al, 2021 PubMed
- "Cancer caused death for ~80% of ITP mice." · Dodds S et al, 2020 PubMed
- "This compound lowers HbA(1c) by 0.5-1% in patients with Type 2 diabetes, either drug naive or in combination with other antidiabetic drugs." · Hanefeld M et al, 2008 PubMed
- "In those with impaired glucose tolerance (IGT), it reduces the incidence of newly diagnosed diabetes by 36.4%." · Hanefeld M et al, 2008 PubMed
- "In a meta-analysis of patients with Type 2 diabetes (MERIA), acarbose intake was associated with a reduction of cardiovascular events by 35%." · Hanefeld M et al, 2008 PubMed
- "Acarbose is a very safe drug but in approximately 30% of patients, it can cause gastrointestinal complaints due to its mode of action, which in the majority disappear after 1-2 months." · Hanefeld M et al, 2008 PubMed
Research and Studies
8 PubMed-indexed papers reference Acarbose. Top 8 shown.
Legal Status
Acarbose is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is Acarbose FDA-approved?
Acarbose is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
How much research has been published on Acarbose?
8 PubMed-indexed paper(s) reference Acarbose in our current research feed. See the Research and Studies section above for citations.